CHU Hopitaux de Rouen

Rouen 76031

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Melanoma

Studies at this site

• A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma — Stopped early